ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
November 19, 2024 01:30 ET
|
ONWARD Medical NV
ONWARD Medical Awarded Grant to Study Potential for ARC
BCI Therapy to Restore Movement after Stroke
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
October 07, 2024 11:05 ET
|
Precision Neuroscience
NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking results today from a pilot study conducted in collaboration with Precision Neuroscience Corporation (Precision), a...
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
July 23, 2024 09:00 ET
|
Precision Neuroscience
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in developing brain–computer interface technology to restore function and autonomy for millions...
Precision Neuroscience Announces World Record for Number of Electrodes Placed On Human Brain
May 28, 2024 09:00 ET
|
Precision Neuroscience
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface company Precision Neuroscience Corporation (Precision) and a neurosurgery team from the Mount Sinai Health System now hold the...
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
April 08, 2024 11:53 ET
|
Precision Neuroscience
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer. An expert in chip...
Precision Neuroscience Expands Clinical Research In Brain–Computer Interface
March 22, 2024 08:30 ET
|
Precision Neuroscience
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
February 29, 2024 01:41 ET
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
October 05, 2023 09:00 ET
|
Precision Neuroscience
NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems...
ONWARD® kündigt die erste Implantation eines ARC-IM™-Stimulators mit Gehirn-Computer-Schnittstelle (BCI) beim Menschen an, um die Arm-, Hand- und Fingerfunktion nach einer Rückenmarksverletzung wiederherzustellen
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), das Medizintechnikunternehmen, das innovative Therapien zur Rückenmarkstimulation entwickelt, um Bewegung,...
ONWARD® annonce la première implantation chez l'homme du stimulateur ARC-IM™ avec interface cerveau-ordinateur pour restaurer les fonctions du bras, de la main et du doigt après une lésion médullaire.
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, 27 sept. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), l’entreprise de technologie médicale spécialisée dans la création de thérapies innovantes pour rétablir le...